Clinical Trials Browser

Interventional × Disease × Genitourinary × Clear all

NCT07398690 2026-03-17

INSIGHT-PCa

Phase NA Recruiting

Disease, Prostatic Neoplasms

NCT07460843 2026-03-12

Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis

Phase NA Recruiting

Disease, Prostatic Neoplasms

NCT07464964 2026-03-11

MUSIC-PRT

Phase NA Completed

Anxiety Disorders, Disease, Prostatic Neoplasms

NCT07369570 2026-02-24

REMRI

Phase NA Recruiting

Disease, Prostatic Neoplasms, Disease Progression

NCT07410676 2026-02-18

EBNK-ST-001

Phase 1/2 Recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Bronchogenic, Disease, Esophageal Neoplasms, Glioblastoma, Kidney Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT07115914 2026-02-17

PSMA PET for Surveillance After Focal Therapy

Phase NA Recruiting

Adenocarcinoma, Disease, Prostatic Neoplasms

NCT07223385 2026-02-03

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

Phase 2 Not yet recruiting

Disease, Prostatic Neoplasms

NCT07243834 2026-01-30

ADHERE

Phase NA Recruiting

Disease, Motor Activity, Prostatic Neoplasms

NCT03173924 2026-01-21

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

Phase 2 Active not recruiting

Disease, Prostatic Neoplasms

NCT07271017 2025-12-08

Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe

Phase 1 Recruiting

Disease, Prostatic Neoplasms

NCT07054346 2025-12-01

LUTACT

Phase 1 Recruiting

Disease, Prostatic Neoplasms

NCT06604130 2025-11-28

exo-PRECISE

Phase NA Enrolling by invitation

Disease, Prostatic Neoplasms

NCT07252297 2025-11-26

NMIBC

Phase NA Active not recruiting

Non-Muscle Invasive Bladder Neoplasms, Disease

NCT06575361 2025-11-25

Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis

Phase NA Completed

Disease, Prostatic Neoplasms

NCT06517901 2025-10-03

FOCUS-PC

Phase NA Recruiting

Disease, Neoplasms, Prostatic Neoplasms

NCT04186845 2025-09-22

Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

Phase 3 Completed

391 enrolled 30 charts

Disease, Prostatic Neoplasms

NCT07162987 2025-09-09

PREPP

Phase NA Recruiting

Disease, Prostatic Neoplasms

NCT05141383 2025-09-08

HOPE

Phase NA Completed

Disease, Prostatic Neoplasms

NCT05151341 2025-07-24

URODX-FGFR3

Phase NA Completed

Urinary Bladder Neoplasms, Disease, Neoplasms

NCT06392737 2025-07-02

Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis

Phase NA Recruiting

Disease, Prostatic Neoplasms

NCT04186819 2025-02-26

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Phase 3 Completed

356 enrolled 28 charts

Disease, Prostatic Neoplasms

NCT03465579 2025-01-30

BIOPSTAGE

Phase NA Terminated

Disease, Prostatic Neoplasms

NCT06362291 2024-11-20

Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial

Phase NA Completed

Disease, Prostatic Neoplasms

NCT05587192 2024-02-12

RPWPB

Phase NA Unknown

Disease, Prostatic Neoplasms

NCT05947188 2024-02-05

CMNDPC

Phase NA Unknown

Disease, Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT04880681 2023-05-01

Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle

Phase NA Unknown

Disease, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT03730324 2023-03-23

ProBioM

Phase NA Completed

Disease, Prostatic Neoplasms

NCT05464576 2022-09-02

IRMAA

Phase NA Unknown

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Disease

NCT05273593 2022-03-10

CLETUR

Phase NA Completed

Urinary Bladder Neoplasms, Disease

NCT01632930 2022-02-03

Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis

Phase NA Completed

Disease, Prostatic Neoplasms

NCT02981368 2021-08-09

OSPREY

Phase 2/3 Completed

385 enrolled 20 charts

Disease, Prostatic Neoplasms

NCT02745496 2021-06-25

MULTIPROS

Phase NA Completed

Disease, Prostatic Neoplasms

NCT04803188 2021-03-17

ProSa-I

Phase NA Unknown

Disease, Prostatic Neoplasms

NCT03335059 2020-04-15

RITE-USA

Phase 3 Terminated

Urinary Bladder Neoplasms, Disease

NCT04079699 2019-09-06

Predicting Prostate Cancer in Elderly Men

Phase NA Not yet recruiting

Disease, Prostatic Neoplasms

NCT02064608 2019-07-17

CaNCaP02

Phase 1 Completed

Disease, Neoplasms, Prostatic Neoplasms

NCT03185182 2019-06-21

RCCSCAN

Phase 2 Terminated

5 enrolled 5 charts

Carcinoma, Renal Cell, Disease

NCT02042053 2017-07-18

PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

Phase NA Terminated

Disease, Prostatic Neoplasms

NCT02524860 2017-03-16

Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device

Phase NA Unknown

Disease, Prostatic Neoplasms

NCT02149862 2016-09-07

FIRBladd

Phase NA Completed

Urinary Bladder Neoplasms, Disease

NCT02825225 2016-07-07

A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes

Phase NA Completed

Disease, Prostatic Neoplasms

NCT00571675 2010-11-09

A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Completed

Disease, Neoplasm Metastasis, Prostatic Neoplasms